3-(Bromomethyl)benzoic acid (cas: 6515-58-8) belongs to organobromine compounds. Bromo compounds are employed in a variety of metal-catalyzed coupling reactions. They are also ideal candidates for the synthesis of Grignard reagents that have wide-applicability in organic synthesis. In the pharmaceutical industry organo bromine derivatives are used as sedatives, vasodilators, antiseptic agents, and anticancer agents.Quality Control of 3-(Bromomethyl)benzoic acid
Novel Multidrug Resistance Reversal Agents was written by Berger, Dan;Citarella, Ron;Dutia, Minu;Greenberger, Lee;Hallett, William;Paul, Rolf;Powell, Dennis. And the article was included in Journal of Medicinal Chemistry in 1999.Quality Control of 3-(Bromomethyl)benzoic acid This article mentions the following:
A series of 59 α-aryl-α-thioether-alkyl, -alkanenitrile, and -alkanecarboxylic acid Me ester tetrahydroisoquinoline and isoindoline derivatives I [R1-R4 = H, F, Cl, OH, OCF3, OMe, OBn, OTBDMS, OCH2CH2Cl, OCH2CH2Im (Im = imidazole), OCH2CH2NMe2, OCH2O; R5 = 4-MeC6H4, cyclohexyl; R6 = CN, CO2Me, H, Et; R7 = H, Me, 3,4-(MeO)2C6H3; R8 = H, OMe; n = 2-6, 8, 11; m = 1,2] were synthesized and evaluated as multidrug resistance (MDR) reversal agents. The compounds were tested on S1-B1-20 human colon carcinoma cells selected for resistance to bisantrene. Both the cytotoxicity of the reversal agents and their ability to resensitize the cells to bisantrene were determined All but two of these compounds were more effective MDR reversal agents in vitro than verapamil (VRP), a calcium channel antagonist which also has been shown to possess MDR modulating activity. Several showed good activity in this assay (IC50‘s < 0.5 μM), the most potent being isoindolines I [R1-R4 = OMe, R5 = 4-MeC6H4, R6 = CN, n = 5, m = 1; R1-R4 = OMe, R5 = C6H11, R6 = CN, n = 5, m = 1] and tetrahydroisoquinolines I [R1 = OCH2CH2Im, R2-R4 = OMe, R5 = 4-MeC6H4, R6 = H, n = 6, m = 2; R1-R4 = OMe, R5 = 4-MeC6H4, R6 = CN, n = 6, m = 2]. A number of compounds were evaluated in vivo against vincristine (VCR)-resistant murine P388 leukemia, as well as against human epidermoid carcinoma KB/8.5 implanted s.c. in athymic mice. The reversal agents which consistently showed the highest activity, together with low toxicity, were α-aryl-α-thiotolylalkanenitrile tetrahydroisoquinoline derivatives with electron-rich alkoxy substituents on the aromatic rings. Of the tested compounds, the most effective reversal agents for both tumor lines were tetrahydroisoquinolines I [R1-R4 = OMe, R5 = 4-MeC6H4, R6 = CN, n = 5, m = 2] (33% increased life span at 12.5 mg/kg, 0.2 mg/kg VCR vs. VCR alone in the VCR-resistant P388 leukemia model and 59% relative tumor growth at 50 mg/kg, 8 mg/kg doxorubicin vs. doxorubicin alone in the KB/8.5 model) and I [R1-R2 and R4 = OMe, R3 = OCH2CH2Im, R5 = 4-MeC6H4, R6 = CN, n = 5, m = 2] (48% increased life span at 50 mg/kg, 0.2 mg/kg VCR vs. VCR alone in the VCR-resistant P388 leukemia model and 46% relative tumor growth at 25 mg/kg, 8 mg/kg doxorubicin vs. doxorubicin alone in the KB/8.5 model). The mechanism of action of these compounds is believed to involve blocking the drug efflux pump, P-glycoprotein. In the experiment, the researchers used many compounds, for example, 3-(Bromomethyl)benzoic acid (cas: 6515-58-8Quality Control of 3-(Bromomethyl)benzoic acid).
3-(Bromomethyl)benzoic acid (cas: 6515-58-8) belongs to organobromine compounds. Bromo compounds are employed in a variety of metal-catalyzed coupling reactions. They are also ideal candidates for the synthesis of Grignard reagents that have wide-applicability in organic synthesis. In the pharmaceutical industry organo bromine derivatives are used as sedatives, vasodilators, antiseptic agents, and anticancer agents.Quality Control of 3-(Bromomethyl)benzoic acid
Referemce:
Bromide – Wikipedia,
bromide – Wiktionary